I've recently had a great conversation with Dr. Andree Bates of the AI For Pharma Growth, discussing innovation, AI, and pharma industry:
They explore the distinction between doing and managing innovation, emphasising the pitfalls to avoid. Bruno highlights the significance of investing wisely, steering clear of ideas with limited market potential. Overcoming executive fear of innovation and understanding market scale are crucial.
They discuss the importance of creating a budget for innovative ideas, releasing funding incrementally, and combining data with human intuition for decision-making. The role of AI is considered, along with risks tied to innovation implementation and metrics for measuring success. They also examine successful business models in pharma, alongside a practical guide to lean experimentation.
You can listen to the episode here or by using the player below:
Subscribe to get the latest posts delivered right to your inbox. No spam. Only Bruno.